Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment

BACKGROUND: Tuberculosis (TB) and chronic Hepatitis B virus (HBV) infection are common in China. Fist-line anti-TB medications often produce drug-induced liver injury (DILI). This study sought to investigate whether TB patients with chronic HBV co-infection are more susceptible to liver failure and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lubiao, Bao, Dujing, Gu, Lin, Gu, Yurong, Zhou, Liang, Gao, Zhiliang, Huang, Yuehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029116/
https://www.ncbi.nlm.nih.gov/pubmed/29970037
http://dx.doi.org/10.1186/s12879-018-3192-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029116/
https://www.ncbi.nlm.nih.gov/pubmed/29970037
http://dx.doi.org/10.1186/s12879-018-3192-8

Ejemplares similares